Skip to main content
. 2018 Jan;10(1):190–195. doi: 10.21037/jtd.2017.11.129

Table 1. Characteristics of the study population.

Parameter All patients (N=74) Dexmedetomidine group (N=31) Midazolam group (N=43)
Gender (male/female) 42/32 18/13 24/19
Age (year) 58.8±12.2 57.2±11.8 59.9±12.5
Height (cm) 168.20±9.04 168.61±9.09 167.91±9.10
Weight (kg) 66.30±9.55 67.55±9.19 65.40±9.81
APACHEII score 16.84±4.62 16.71±4.79 16.93±4.54
Indications for fiberoptic bronchoscopy (examination diagnosis/bronchoalveolar lavage) 24/50 10/21 14/29
Remedial sedation by propofol (yes/no) 37/37 22/9 15/28
Total sedation time (min) 25.20±4.35 27.87±4.10 23.28±3.44
Time of FFB (min) 18.37±3.78 19.77±3.79 17.36±3.48
Satisfaction score of the bronchoscopists 7.36±1.88 7.03±2.07 7.60±1.71
Cough (yes/no) 29/45 17/14 12/31
Nausea (yes/no) 13/61 5/26 8/35
Bronchospasm (yes/no) 33/41 19/12 14/29
Tachycardia (yes/no) 26/48 11/20 15/28
Bradycardia (yes/no) 7/67 3/28 4/39
Arrhythmia (yes/no) 6/68 3/28 3/40
Oxygen desaturation (yes/no) 26/48 15/16 11/32
Hypotension (yes/no) 12/62 5/26 7/36
Hypertension (yes/no) 13/61 6/25 7/36

APACHE II score, acute physiology and chronic health evaluation II score; Satisfaction score, consistency between respiratory therapist and nurse on the comments of the bronchoscopists. FFB, flexible fiberoptic bronchoscopy.